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Abstract
Background: Little is known about changes in disability over time among community-dwelling patients. Accordingly,
this study sought to assess medium-term disability transitions.
Patients and Methods: 300 chronic obstructive pulmonary disease (COPD), chronic heart failure and stroke patients
living at home in Madrid were selected from general practitioner lists. In 2009, disability was assessed after a mean
of 30 months using the World Health Organisation (WHO) Disability Assessment Schedule 2.0 (WHODAS 2.0).
Follow-up was completed using death registries. Losses to follow-up were due to: death, 56; institutionalisation, 9;
non-location, 18; and non-participation, 17. Changes in WHODAS 2.0 scores and life status were described and
analysed using Cox and multinomial regression. Disability at end of follow-up was imputed for 56 deceased and 44
surviving patients.
Results: Mean disability scores for 200 surviving patients at end of follow-up were similar to baseline scores for the
whole group, higher than their own baseline scores, and rose by 16.3% when imputed values were added. The
strongest Cox predictors of death were: age over 84 years, adjusted hazard ratios with 95%CI 8.18 (3.06-21.85);
severe/complete vs. no/mild disability, 5.18 (0.68-39.48); and stroke compared to COPD, 1.40 (0.67-2.91). Non-
participants and institutionalised patients had higher proportions with severe/complete baseline disability. A one-point
change in baseline WHODAS 2.0 score predicted independent increases in risk of 12% (8%-15%) for severe/
complete disability or death.
Conclusions: A considerably high proportion of community-dwelling patients diagnosed with COPD, CHF and stroke
undergo medium-term changes in disability or vital status. The main features of the emerging pattern for this group
appear to be as follows: approximately two-thirds of patients continue living at home with moderately reduced
functional status; 1/3 die or worsen to severe/complete disability; and 1/10 improve. Baseline disability scores, age
and diagnosis are associated with disability and death in the medium term.
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Introduction
Disability assessment in clinical practice has been used to
monitor individual patient outcomes. In addition, predicting
negative outcomes, such as severe disability or death, can be
relevant when it comes to planning care and preventive
measures. In this paper, particular attention is given to
assessing disability in primary care, whether directly or, in e-
health research settings, using Information Communication
Technologies (ICTs).
Diverse forms of monitoring appear to provide efficient and
effective methods of delivering integrated care in the home
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health sector [1,2]. Disability, as a component of the routine
follow-up of chronically ill elderly persons, has been proposed
as a means of improving service provision in cases of frailty
[3,4]. In the field of disability monitoring, however, both in
traditional care and using ICTs, there is ample room for
developing an instrument of choice, examiner profile, indication
and adaptation to data-collection procedures. A relevant
hindrance to development and application to diagnostic groups
is the limited information on expected disability transitions
during specific intervals of patients' life course.
The International Classification of Functioning, Disability and
Health (ICF) model constitutes an extensive and universally
accepted taxonomic classification of disability, which enables
clinicians to describe patients' functioning and disability
comprehensively and categorise this in a systematic and
standardised manner [5,6]. The World Health Organisation
(WHO) Disability Assessment Schedule 2.0 (WHODAS 2.0), 36
items version (WHODAS-36) is an ICF disability instrument
which has successfully shown its usefulness for monitoring
patients' outcomes in clinical practice and in clinical trials of
treatment effects (for a review see Üstün et al [7]). Versions for
self- and lay proxy-informants have been developed.
In 2009, disability was measured using the WHODAS-36 on
three groups of Spanish, home-dwelling, primary-care patients
who suffered from chronic obstructive pulmonary disease
(COPD), chronic heart failure (CHF) and stroke [8]. This
instrument was deemed suitable for monitoring the health
status of elderly persons living at home [8]. In order to detect
negative outcomes in the above cohort, this study focused on
assessing disability by the same method and ascertaining
mortality across a 30-month follow-up.
Patients and Methods
The instrument used
The 36-item version of the WHODAS 2.0 is a disability scale
focusing on the ICF Activities and Participation chapters,
described in the Table S1. Each item is scored from 0-4; these
points are then expressed as a percentage of the maximum
theoretical score, and constitute the official disability score of
0-100. This score is, in turn, systematically categorised into no
(0%-4%), low (5%-24%), moderate (25%-49%), severe
(50%-95%), and extreme or complete (96%-100%) disability.
Items addressing occupational status were generically treated,
e.g., with work tasks being deemed to be those performed by
retired persons actively involved in doing productive unpaid
work [9]. The sexuality item was also excluded from the
analysis, owing to a high proportion of missing values. The Life
Activities domain was assessed in terms of domestic life solely
among participants who still performed such activities, i.e.,
thereby avoiding the need to record the traditionally low
performance of men. In line with reported methods [8–10],
missing data for items with less than 30% of missing values
were replaced by the mean of the remaining domain values,
and in cases where 30% or more of values were missing, the
domain was left blank. Individuals with more than one blank
WHODAS 2.0 domain were excluded from the analysis. The
WHODAS-36 has been extensively tested and shown to be an
easily administered, robust instrument [7].
Baseline assessment
A prevalence survey of 26 chronic diseases considered to
generate high figures was conducted on the population aged
>14 years of the Southern Madrid Region, traditionally a
residential area (see Carmona et al 2010 for detailed methods
and survey CHF outcome [11]). As indicated in a prior report,
COPD, CHF and stroke were judged to be diagnostic groups
appropriate for a disability study, in view of their higher
prevalence and mean individual use of health resources as
compared to the above-mentioned remaining 23 chronic
conditions [8]. Data, subjected to the application of reported
quality criteria, were obtained from the electronic medical
records of 129 physicians. Patients were deemed to present
with COPD, CHF or stroke where they had an International
Classification of Primary Care diagnostic code R79 or R95 for
COPD, K77 for CHF, and K90 or K91 for stroke, and had made
a medical visit in 2007. This procedure made it possible to
identify 3183, 1377 and 2658 patients, who yielded
prevalences of 21, 9 and 18 per 1000 population for COPD,
CHF and stroke respectively [8]. After verification of life status,
a subsample of 1053 patients, balanced in terms of each
diagnostic category, was used to obtain residence at home or
willingness to participate, with the three convenience samples
of patients diagnosed with COPD, 102, CHF, 99, and stroke,
99, constituting the group chosen to undergo disability
assessment [8]. During the period April to September 2009,
these patients were assessed at home by trained field workers
using the WHODAS 36-item version. In essence, the sample
corresponded to a community-dwelling population in South
Madrid having a low educational and low income level: for a
more detailed account of patient selection, the participation
rate, details of the WHODAS 2.0 measurements and a
description of the sample's educational, economic and social
characteristics, readers are referred to the baseline study
report [8].
The 12 de Octubre Hospital Research Ethics Committee
approved the baseline study in February 2009 (report 09/42),
and the follow-up study, verbally in September 2011 and
formally in January 2011 (by an amendment to the 09/42
report). Participants gave written informed consent to
participating in the baseline (W1) assessment and verbal
informed consent to being assessed in W2.  Following
consultation with the above-mentioned Ethics Committee in
September 2011, written consent was not deemed necessary
for W2 in view of the fact that both the patients and questions
(WHODAS 2.0) used for the purposes of W1 were identical to
those used for the purposes of W2.
Follow-up
In October 2011, after examining The Madrid Regional Death
Registry and verifying that 56 (18.7%) out of the 300 patients
had died, letters were sent to the remaining 244 patients or
their relatives, inviting them to participate in a new evaluation at
home and advising them that they would receive a telephone
call. Telephone calls were made once or twice from November
Disability Transitions
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to December 2011. Eighteen patients (6.0%) were not located
and 17 (5.7%) refused to participate. Nine (3%) patients had
been institutionalised. One hundred and twenty-nine patients
were assessed at home, 14 by proxy. Fifty-eight patients and
13 proxies answered the questionnaire by telephone. In all, 200
patients -77 diagnosed with COPD, 63 with stroke and 60 with
CHF- had valid assessment results at baseline (W1) and
follow-up (W2). Successful follow-up was achieved for 282 out
of the 300 patients, with the above-mentioned 18 patients who
proved impossible to locate by mail or telephone being
classified as lost to follow-up.
Data analysis
Mortality for the different variables was studied using Cox
regression models. We obtained hazard ratios (HRs) adjusted
for age (attained age was used as the time scale), sex and
diagnostic group.
With regard to disability, total WHODAS scores [10] were
calculated and categorised in accordance with the five severity
levels described above. In order to study the effect of W1
variables on outcomes, we created a four-category outcome
variable encompassing three disability score intervals in W2
(none or low [0-24 points], moderate [25-49 points] and severe/
complete [50-100 points]) and deceased during follow-up. In
addition, we calculated the probabilities of these outcomes for
the same disability categories in W1. Adjusted probabilities
were computed with the aid of a multinomial logistic model that
included age, sex and diagnostic group.
In order to assess WHODAS scores on the assumption that
all baseline subjects had been measured in W2, we used
multiple imputation [12,13] for the 56 subjects who had died
and the 44 who had not been completely followed-up. We
obtained 10 W2 WHODAS-score imputed data sets using a
linear regression model that included age, sex, diagnostic
group and W1 WHODAS scores. We then computed pooled
mean scores with the 10 imputed data sets, and standard
errors by taking the within- and between-imputation
components into account. An imputation procedure excluding
the 56 deceased patients was also performed.
Results
Of the 300 participants at baseline, the above-described 282
were followed up for a median of 2.4 years. In the case of the
18 patients who could not be traced, the reason frequently
given by neighbourhood informants to explain this was a
change of address, whether the new residence was unknown
or known, institutional or non-institutional. Age at baseline of
the 282 study participants ranged from 28 to 98 years, with a
median of 77 and a mean (SD) of 75 (11.4) years. Figure 1
depicts W1 to W2 attrition, which was 33% overall, and 37% for
CHF and stroke, with losses being highest among patients with
stroke, 10/99, 10%. The proportion of deceased was highest
among those with CHF, 24/99, 24%.
Table 1 shows the characteristics of the 300 patients in W1,
and of 200 in W2, both overall and by diagnostic group. Mean
W1 WHODAS scores were 33.8 for all patients, 26.4 for COPD,
38.0 for CHF and 37.2 for stroke, and were practically
unchanged in W2. Compared to the whole group in W1, the 18
patients lost to follow-up: were an average of 8.8 years
younger, with only one subject aged ≥85 years; comprised
mainly men, with an F/M ratio of 1/2; had a high stroke
frequency (10 subjects) and a higher degree of disability; and
registered a mean (SD) WHODAS score of 44.7 (23.5), all of
which suggested a profile clearly different from that of baseline
participants.
A detailed breakdown of the study population by diagnostic
group is depicted in Figure 2, in which disability categories from
Figure 1.  Attrition at follow-up for all patients and diagnostic groups.  
doi: 10.1371/journal.pone.0077482.g001
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direct assessments are shown for each diagnostic group and
subgroup: firstly in W1, for all patients, for those who were
followed-up, for those who died and for the subgroup denoted
as "other", including those lost to follow-up and non-
participants; and secondly in W2, for all those who were
assessed. In W1, the proportions of severely disabled among
deceased and "other" (lost and non-participant) patients were
systematically the highest. For those assessed in W1 and W2,
the proportions of severely disabled remained unchanged for
stroke, while a worsening trend was suggested for CHF and
COPD. The corresponding mean W1 scores of 30.7, 32.3 and
22.6 worsened to 35.7, 36.2 and 26.7 respectively. In brief, in
W1, patients who were not assessed in W2 and those who
subsequently died were more disabled than those who were
assessed after follow-up; all diagnostic groups worsened
across follow-up.
The mortality rate for the population aged ≥60 years was
99.0 per 1000 person-years (fifty-six deaths during 565 person-
year follow-up); the cumulative incidence of death was 20%
(56/282) (95%CI: 15-25%). Adjusted hazard ratios (HRs) for
death are shown in Table 2. Higher HRs were seen for subjects
with ages ≥85 years at baseline (HR= 8.18), severe/complete
disability (HR= 5.18) and need of professional help (HR= 3.24).
A breakdown by diagnosis showed that the highest mortality
rate was attributable to stroke, followed by CHF and COPD. No
association was seen with resource utilisation level [14].
Table 3 shows the probabilities of a patient classified in any
given disability category in W1 being in the same or a different
disability category or having died in W2; based on raw data, the
probability was highest for the transition from severe disability
to death, 47.5% (35.4%-60.0%). Of the 300 patients: 112,
37.3%, worsened to severe/complete disability or death; 25,
8.3%, worsened to moderate disability; and 32, 10.7%,
improved to moderate or lower disability. The remaining 131,
43.7%, remained at the same disability level. Improvement
from severe/complete to no/mild disability scores was unlikely.
Adjustment for age, sex, and diagnosis did not substantially
modify the results.
A post-follow-up view of the above-mentioned three disability
categories (none/mild, moderate, severe/complete), overall and
by diagnostic subgroup, is graphically depicted in Figure 3.
Worsening (transition to higher disability or death) was 39%
overall, with the corresponding figures by diagnostic group
being 37% for stroke, 45% for CHF and 34% for COPD. In the
case of diagnostic and disability sub-groups, worsening was
approximately 1/3 for disability sub-categories, proving lowest
for COPD with no/mild disability and stroke with moderate
disability, both of which displayed high proportions with the
same disability levels in W1 and W2. The vast majority of
patients who were severely/completely disabled in W1, score
≥50, remained severely disabled in W2 or had died, both
overall and by group, with the highest mortality seen for CHF.
Predictors for outcome categories of disability and death
were analysed for 256 patients, using multinomial logistic
regression models (Table 4) where relative risk ratios (RRRs)
for each outcome are shown, taking no/mild disability as the
Table 1. Descriptive information by diagnostic group and wave.
  COPD Chronic heart failure Stroke Total
Variable Category W1 W2 W1 W2 W1 W2 W1 W2
 All 102 (100) a 76 (100) 99 (100) 62 (100) 99 (100) 62 (100) 300 (100) 200 (100)
Sex Female 38 (37.3) 29 (38.2) 53 (53.5) 35 (56.5) 46 (46.5) 27 (43.5) 137 (45.7) 91 (45.5)
 Male 64 (62.7) 47 (61.8) 46 (46.5) 27 (43.5) 53 (53.5) 35 (56.5) 163 (54.3) 109 (54.5)
Age (years) <75 23 (22.5) 17 (22.4) 9 ( 9.1) 6 ( 9.7) 17 (17.2) 9 (14.5) 49 (16.3) 32 (16.0)
 75-84 24 (23.5) 14 (18.4) 16 (16.2) 10 (16.1) 26 (26.3) 18 (29.0) 66 (22.0) 42 (21.0)
 ≥85 55 (53.9) 45 (59.2) 74 (74.7) 46 (74.2) 56 (56.6) 35 (56.5) 185 (61.7) 126 (63.0)
Marital status Without spouse/partner 39 (38.2) 29 (38.2) 49 (49.5) 25 (40.3) 35 (35.4) 26 (41.9) 123 (41.0) 80 (40.0)
 With spouse/partner 63 (61.8) 47 (61.8) 50 (50.5) 37 (59.7) 64 (64.6) 36 (58.1) 177 (59.0) 120 (60.0)
Occupational status Active 18 (17.6) 15 (19.7) 12 (12.1) 14 (22.6) 14 (14.1) 11 (17.7) 44 (14.7) 40 (20.0)
 Retired 78 (76.5) 60 (78.9) 82 (82.8) 47 (75.8) 81 (81.8) 48 (77.4) 241 (80.3) 155 (77.5)
 Other 6 ( 5.9) 1 ( 1.3) 5 ( 5.1) 1 ( 1.6) 4 ( 4.0) 3 ( 4.8) 15 ( 5.0) 5 ( 2.5)
Baseline living/residential situation Independent-no services 67 (65.7) 53 (69.7) 40 (40.8) 33 (53.2) 43 (44.3) 29 (48.3) 150 (50.5) 115 (58.1)
 Family support 20 (19.6) 14 (18.4) 34 (34.7) 19 (30.6) 38 (39.2) 25 (41.7) 92 (31.0) 58 (29.3)
 Professional help 15 (14.7) 9 (11.8) 24 (24.5) 10 (16.1) 16 (16.5) 6 (10.0) 55 (18.5) 25 (12.6)
Educational level Less than primary 16 (15.7) 7 ( 9.2) 10 (10.5) 8 (12.9) 9 ( 9.1) 2 ( 3.2) 35 (11.8) 17 ( 8.5)
 Primary 43 (42.2) 33 (43.4) 43 (45.3) 31 (50.0) 42 (42.4) 37 (59.7) 128 (43.2) 101 (50.5)
 Secondary or higher 43 (42.2) 36 (47.4) 42 (44.2) 23 (37.1) 48 (48.5) 23 (37.1) 133 (44.9) 82 (41.0)
Disability level No/Mild 56 (54.9) 47 (61.8) 32 (32.3) 20 (32.3) 41 (41.4) 24 (38.7) 129 (43.0) 91 (45.5)
 Moderate 31 (30.4) 14 (18.4) 38 (38.4) 27 (43.5) 25 (25.3) 23 (37.1) 94 (31.3) 64 (32.0)
 Severe/complete 15 (14.7) 15 (19.7) 29 (29.3) 15 (24.2) 33 (33.3) 15 (24.2) 77 (25.7) 45 (22.5)
Disability score, mean (SD)  26.4 (20.8) 26.7 (20.9) 38.0 (23.2) 36.2 (19.2) 37.2 (27) 35.7 (25.6) 33.8 (24.3) 32.5 (22.3)
Abbreviations: COPD: chronic obstructive pulmonary disease. W1, W2: Waves 1 and 2.
a. Absolute numbers (percentages).
doi: 10.1371/journal.pone.0077482.t001
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Figure 2.  Prevalence of disability categories in three diagnostic groups and several subgroups: all patients at baseline
(left); other=non-participants and institutionalised (centre left); deceased during follow-up (centre); and followed-up
community-dwelling residents at baseline (centre right) and end of follow-up (right).  
doi: 10.1371/journal.pone.0077482.g002
Disability Transitions
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reference outcome category. Age and W1 disability appeared
to be strong, systematic predictors of negative outcomes
(disability and death). The relative risk ratio per year of age,
was highest for severe/complete disability (RRR= 1.13
(1.07-1.19)) and death (RRR=1.15 (1.09-1.2)). Similarly, high
increases in risk per disability point score were seen for severe/
complete disability or death (RRR= 1.12 (1.08-1.12) in both).
Available family support and married status were associated
with severe/complete disability in W2 (RRR=10.72 (2.99-38.45)
and RRR=4.56 (1.39-14.93) respectively).
Figure 4 shows mean disability scores with their 95%CIs for:
(a) 300 patients in W1, 33.8; (b) 200 patients assessed in W2,
32.5; (c) 200 patients assessed in W2, with imputed values for
41 surviving patients, 34.0; and, (d) 200 survivors plus imputed
values for 96 patients who were dead or alive, 37.8. While
minor differences were seen between comparisons using only
direct assessments in W1 and W2, and assessed plus imputed
Table 2. Mortality hazard ratios for demographic and disability variables.
Variable Category HR a (95% CI)
Sex Female 1
 Male 0.71 (0.40-1.26)
Age (years) <75 1
 75-84 4.79 (1.84-12.45)
 ≥85 8.18 (3.06-21.85)
Marital status With no spouse/partner 1
 With spouse/partner 0.99 (0.52-1.89)
Occupational status Active 1
 Retired 2.73 (0.63-11.93)
 Other b 6.10 (0.97-38.51)
Living/residential situation Independent-no services 1
 Family support 1.78 (0.83-3.85)
 Professional help 3.24 (1.48-7.09)
Educational level Less than primary 1
 Primary 0.54 (0.23-1.28)
 Secondary and higher 0.86 (0.36-2.02)
Diagnostic group COPD 1
 Chronic heart failure 1.19 (0.58-2.44)
 Stroke 1.40 (0.67-2.91)
Disability level No problem 1
 Mild disability 1.52 (0.19-12.32)
 Moderate disability 3.22 (0.42-24.92)
 Severe/complete disability 5.18 (0.68-39.48)
Resource utilisation bands [14] Moderate/low cost 1
 High cost 1.33 (0.68-2.70)
a. Hazard ratio, adjusted for age, sex and diagnostic group
b. On temporary leave, pre-retirement
doi: 10.1371/journal.pone.0077482.t002
Table 3. Probability of follow-up outcome by baseline disability level.
  Outcome Probability, % (95% CI)
 Baseline disability level No. of patients No/mild Moderate Severe/complete Death
Crudea No/mild 110 64.5 (55.2-72.9) 19.1 (12.8-27.5) 7.3 (3.7-13.9) 9.1 (5.0-16.1)
 Moderate 85 22.4 (14.7-32.4) 41.2 (31.2-51.9) 16.5 (10.0-25.9) 20.0 (12.8-29.8)
 Severe/complete 61 1.6 (0.2-10.7) 13.1 (6.7-24.1) 37.7 (26.5-50.4) 47.5 (35.4-60.0)
Adjustedb No/mild 110 61.8 (51.1-71.5) 22.6 (15.1-32.6) 7.0 (3.4-14.1) 8.5 ( 4.3-16.0)
 Moderate 85 19.7 (11.9-30.7) 44.1 (32.9-55.9) 17.5 (10.3-28.1) 18.8 (11.3-29.5)
 Severe/complete 61 1.9 (0.2-13.5) 15.2 (7.3-28.8) 41.9 (27.9-57.5) 41.0 (27.0-56.6)
a. Correspond to overall values in Figure 4
b. Adjusted for age, sex and diagnosis.
doi: 10.1371/journal.pone.0077482.t003
Disability Transitions
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Figure 3.  Distribution of outcomes (disability levels and death) at end of follow-up for each of three baseline disability
levels, overall and by diagnostic group.  Fragments above solid, thick bands indicate worsening with respect to baseline values.
doi: 10.1371/journal.pone.0077482.g003
Disability Transitions
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values for surviving patients, the fourth group, in which imputed
values for deceased patients were included, displayed the
highest values, i.e., 11.8% higher than those assessed in W1
and 16.3% higher than those assessed in W2.
Table 4. Outcome relative risk ratios from multinomial models.
Variable Category Moderate disability Severe/complete disability Death
Sex Male 0.51 (0.24-1.09) 1.09 (0.42-2.86) 0.94 (0.37-2.41)
Age, per 1 year  1.05 (1.01-1.08) 1.13 (1.07-1.19) 1.15 (1.09-1.22)
Marital status With spouse/partner 1.08 (0.47-2.46) 4.56 (1.39-14.93) 1.51 (0.50-4.51)
Occupational status, Retired/ other 1.25 (0.4-3.88) 0.35 (0.09-1.46) 2.04 (0.33-12.52)
Living/residential situation Independent-no services 1 1 1
 Family support 1.71 (0.64-4.57) 10.72 (2.99-38.45) 2.94 (0.88-9.77)
 Professional help 0.80 (0.20-3.24) 1.88 (0.37-9.46) 1.61 (0.37-7.04)
Educational level Less than primary 1 1 1
 Primary 0.47 (0.13-1.64) 0.65 (0.14-2.95) 0.49 (0.11-2.22)
 Secondary or higher 0.18 (0.05-0.67) 0.76 (0.16-3.55) 0.82 (0.18-3.72)
Diagnostic group COPD 1 1 1
 Chronic heart failure 2.43 (0.96-6.12) 0.71 (0.23-2.22) 1.19 (0.39-3.68)
 Stroke 3.48 (1.39-8.68) 1.62 (0.52-5.03) 2.28 (0.72-7.16)
W1 Disability Score, per 1-point  1.07 (1.04-1.10) 1.12 (1.08-1.15) 1.12 (1.08-1.15)
Abbreviations: COPD: chronic obstructive pulmonary disease.Adjusted for age, sex, diagnostic group and baseline WHODAS-2 score
No/mild disability taken as reference outcome category
doi: 10.1371/journal.pone.0077482.t004
Figure 4.  Mean and 95%CI of WHODAS disability scores for: all patients at baseline (W1, left); survivors at end of follow-
up (W2, centre-left); survivors at end of follow-up in W2, with imputed values for subjects alive but not-assessed in W2
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Discussion
The results of this study describe the main features of
disability across time among persons who were living at home
in a Southern European suburban environment and were
chronically ill with one of three somatic disorders. Our follow-up
disclosed: (a) a considerable impact of death on sample
attrition; (b) a modest increase in disability among survivors;
and, (c) similar main determinants of death or worsened
disability, i.e., age, baseline disability and diagnosis.
Limitations on interpreting results were determined by losses
during follow-up, instability linked to sample size, and a lack of
control based on relevant variables such as cognitive status or
co-morbidity. Since death registration among residents of the
Madrid Region is acknowledged to be of high quality, any
potential selection bias in losses to follow-up would mainly
affect disability. External validity is limited by choice of
diagnosis and recruitment. The good agreement between self-
and proxy-reported current health problems of elderly people
[15] and the low proportion of proxy responses, 14.6% overall,
suggest a low underlying bias.
Mortality was high in this group. Compared to the general
population (based on age- and sex-specific mortality rates
obtained through official statistics for the Madrid Region, 2010),
mortality was more than double, with a standardised mortality
ratio (SMR) of 2.11 (95%CI, 1.56-2.67). However, the
corresponding figures stratified by sex revealed a clear
difference, with SMR=1.37 (95%CI, 0.82-1.92) for men and
SMR=2.94 (95%CI, 1.92-3.97) for women. Although the overall
high mortality of the study sample was expected, the
differential pattern by gender was unforeseen because here in
Spain registered age-adjusted vascular-disease and all-cause
mortality is lower among women than among men [16].
As seen from multinomial analysis, baseline age and
disability are clear predictors of severe disability and death.
Such associations fit the well-known pattern of transitional
disability, i.e. generally worsening with proximity to death [17].
Since death removes persons from the population at risk of
disability, and severe disability in particular, a competing risks
scenario is suggested. Nevertheless, its relevance for use of
specific analytical methods [18] in disability follow-up studies is
beyond the scope of this paper.
Several associations may be related to community living.
Living at home with professional help (mainly aid with domestic
tasks) is associated with death, and living with family support is
strongly associated with severe disability, taking independent
living as reference. The magnitude of the association with
professional help decreased when adjusting for baseline
disability (see Table 4), something that suggests confounding
and, in turn, that other factors would determine the link
between professional help and disability in W2. In all likelihood,
such associations could in part be explained by resource
availability, a feature that makes it possible for some severely
disabled persons to live at home.
The finding of high disability in W2 when imputed values for
deceased patients were included, is consistent with the
predictive value of disability for death and may suggest that
transition to death was framed in a scenario where, in addition
to high disability scores, a worsening in disability was
expected. The difference in mean disability scores between
patients assessed in W1 and assessed and imputed values for
patients alive in W2 may suggest disability-related loss or non-
participation. Lower disability among younger cohorts has been
described in Spanish elderly [19,20] and other populations. An
emerging effect of mortality removing older birth cohorts in our
results is unlikely, however.
The moderate disability increase registered by each
diagnostic group between W1 and W2 appears to be in line
with the natural history of COPD and CHF as known,
progressive disorders. For stroke, a disorder generally followed
by at least partial recovery, a worsening in disability might not
have been anticipated if patients with recent stroke had been
included in sample. Recruitment in 2007 implies, not only that
patients were assessed in W1 and W2, several years after the
episode determining stroke diagnosis, but also that recovery
had already taken place. The fact that patients followed up
across the 12 month-5 year interval after the stroke episode in
Stockholm showed a significant decrease in the proportion of
independent living according to the Katz Extended ADL Index
[21], suggests that our findings of increased disability long after
stroke are consistent with reported functional loss in the life
course of elderly stroke patients.
Relationships between diagnoses, disease course and
disability in W1 and W2 in our sample can be complex. A
straightforward interpretation of the associations, whereby all
disability is attributed to the effect of the specific diagnosis, is
probably misleading, despite the fact that CHF, COPD and
stroke may determine disability, for the simple reason that
disability determined by other health conditions cannot be ruled
out. For instance, a random sample of Finnish subjects aged
65-74 years showed that, after adjustment for age and co-
morbidity, cerebrovascular diseases in men and myocardial
infarction, heart failure and cerebrovascular diseases in women
were significantly associated with disability [22]. Nevertheless,
only part of the disability -33% in men and 24% in women- was
attributable to cardiovascular disease, excluding hypertension
alone. This would suggest that, in our sample, CHF-, COPD-
and stroke-related disability were pooled with disability of other
aetiologies, and age-related co-morbidity in particular.
Moreover, since in adults at risk of stroke, disproportionate
limitations in activities of daily living, attributed to stroke risk
factors such as diabetes, emerge well before stroke onset [23],
W1 and W2 disability should not be entirely attributed to the
effects of acute stroke.
Different disability trajectories in COPD, CHF and stroke
might be attributable to differential co-morbidity, a feature
reflected by their inclusion as components of different reported
multimorbidity patterns. Using factor analysis on large
prevalent samples of primary care diagnoses of chronic
conditions among the elderly, two groups in Germany and
Spain identified three and four similar patterns respectively
[24,25]. In both studies, stroke constitutes a component of the
factor denoted as “neuropsychiatric disorders” or
“psychogeriatric”, where dementia and other highly disabling
degenerative diseases are present and COPD remains a
factor-unrelated condition. In contrast, CHF is included,
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particularly among elderly women, in two factors, namely,
“psychogeriatric”, as mentioned above, and “cardio/metabolic”.
It could be speculated that a fraction of the excess disability
and mortality seen for CHF and stroke as compared to COPD,
may be due to differential co-morbidity, and that co-morbidity
may serve to explain similarities better than it does to explain
differences in transitions between stroke and CHF.
An additional difficulty when it comes to interpreting
associations between diagnoses representing binary
categories of health conditions which are partly treatable and
thus represent different severity levels, is that the disease-
disability association can be bidirectional, inasmuch as
disability may worsen recovery or disease course. This is well
illustrated by the many (often nursing) reports of studies on
CHF patients, aimed at assessing the impact on CHF course of
limitations in self-care, attributed, among other things, to
personality, depression or cognitive decline [26–28]. In
contrast, adequate self-care was linked to an improvement in
health status, a decrease in the number and duration of
hospitalisations, and a decline in the levels of stress
biomarkers and intrathoracic impedance [29]. Hence, if
optimising self-care might, in theory, help improve disease
course and prognosis, one could hypothesise that a negative
disease course due to limitations in self-care might bring about
a worsening to higher disability or death, at least in the case of
CHF patients. Unfortunately, the effect of interventions to
enhance self-management support for patients with COPD and
other chronic conditions is still being debated [30].
A tantalisingly similar interpretation would be that the sex
differential in disability may be the factor determining the sex
differential observed in mortality. It is well known that among
elderly women, prevalence of disability is higher than among
elderly men, and this trait has also been described by
WHODAS 36-item measurements in Spanish populations aged
≥75 years [31]. The fact that global baseline disability in our
sample, particularly for stroke patients, was higher among
women (odds ratio 2.80 95%CI 1.12-6.97) [8] might support
such an interpretation. One could speculate that co-morbidity,
rather than limitations in self-care alone, generating the higher
prevalence of disability among women might also contribute to
the sex differential in the mortality pattern observed.
In this study attention has focused on global disability scores,
neglecting the picture for specific domains such as Getting
around or Self-care. A domain-specific approach might be
more sensitive to specific disability transitions, since domain-
specific disability, even at a high level, can be concealed by
dilution in global scores. Individual monitoring targets including
disability, may differ for diagnoses and for elderly presenting
with multiple diagnoses, and may therefore have to be
individually designed. Abete et al suggest that self-care
management, caregiver training and multiprofessional teams
represent the critical point for treatment of elderly CHF patients
and that follow-up of elderly CHF patients is extremely
important [32]. Similar approaches have been suggested for
home-based rehabilitation of stroke patients, where combined
monitoring of rehabilitation, anticoagulation and other
techniques have been tested [33,34]. In future, appropriate
disability monitoring design, including indication, may go
towards maximising the still limited evidence supporting the
contention that ICT-based monitoring performs better than
does traditional care in reducing both the decline in frailty
states and death [35].
Conclusions
To sum up, this study shows that disability and death are
associated with baseline disability scores, age and diagnosis.
At 30 months, two out of three COPD, CHF and stroke patients
continued living at home with reduced functional status, one in
three had died or worsened to severe/complete disability, and
one in ten had improved to lower disability. Transitions by
disability domain may differ from results for global disability and
warrant specific approaches.
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